Global Immunoprotein Diagnostic Testing Market

Immunoprotein Diagnostic Testing Market Size, Share, Growth Analysis, By Test (Complement System Proteins Diagnostic Tests, Free Light Chain Diagnostic Tests), By Application, By Technology, By End Use, By Distribution Channel, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35A2600 | Region: Global | Published Date: November, 2025
Pages: 157 |Tables: 66 |Figures: 75

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Immunoprotein Diagnostic Testing Market size was valued at USD 9.61 Billion in 2024 and is poised to grow from USD 10.3 Billion in 2025 to USD 17.96 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026–2033).

    The global immunoprotein diagnostic testing market's competitive landscape features a dynamic interplay of established players and innovative entrants striving to capture market share. Key industry participants such as Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers continue to dominate with their comprehensive product portfolios, extensive distribution networks, and strong R&D capabilities. However, emerging companies like Bio-Rad Laboratories and Ortho Clinical Diagnostics are gaining traction by focusing on novel technologies, strategic collaborations, and niche diagnostic solutions, intensifying competition and fostering technological advancements in immunoprotein diagnostic testing. 'Abbott Laboratories (USA) ', 'Roche Diagnostics (Switzerland) ', 'Siemens Healthineers (Germany) ', 'Thermo Fisher Scientific (USA) ', 'Danaher Corporation (USA) ', 'Eurofins Scientific (Luxembourg) ', 'Qiagen N.V. (Netherlands) ', 'Fujifilm Holdings Corporation (Japan) ', 'DiaSorin S.p.A. (Italy) ', 'Bio-Rad Laboratories, Inc. (USA) ', 'Sekisui Medical Corporation (Japan) ', 'Ortho Clinical Diagnostics (USA) ', 'Beckman Coulter, Inc. (USA) ', 'Myriad Genetics, Inc. (USA) ', 'Alere Inc. (USA) ', 'Quest Diagnostics Incorporated (USA) ', 'LabCorp (USA) ', 'BioMérieux SA (France) ', 'ARUP Laboratories (USA) ', 'MSD (Merck & Co., Inc.) (USA) '

    One driver of the global immunoprotein diagnostic testing market is the increasing prevalence of infectious and chronic diseases, propelling the demand for accurate and timely diagnosis. Immunoprotein tests play a crucial role in identifying conditions such as cancer, autoimmune disorders, and infectious diseases. The rising awareness of early disease detection and the development of advanced diagnostic technologies are further fueling market growth.

    The global immunoprotein diagnostic testing market is witnessing significant trends that are shaping its landscape. The increasing prevalence of infectious and chronic diseases is driving the demand for accurate and efficient diagnostic tools, leading to the expansion of the immunoprotein testing market. Technological advancements, such as the development of multiplex immunoassay platforms and point-of-care testing options, are enabling rapid and precise results. Moreover, the growing focus on personalized medicine and biomarker research is further propelling the adoption of immunoprotein diagnostic tests. Additionally, collaborations between industry players and research institutions are fostering innovation and driving market growth.

    The global immunoprotein diagnostic testing market exhibits diverse regional trends. North America commands a significant share due to advanced healthcare infrastructure and high R&D investments. Europe follows suit with a strong emphasis on early disease detection and a growing elderly population. In Asia, rapid urbanization and increasing healthcare expenditure propel market growth, while Latin America and the Middle East display rising awareness about diagnostic advancements. Africa lags behind due to limited access to advanced healthcare facilities. Overall, the market's trajectory varies across regions, shaped by factors such as economic development, healthcare policies, and technological adoption.

    Related Reports

    Immunodiagnostics Market
    Buy Now GET FREE SAMPLE
    Autoimmune Disease Diagnostics Market
    Buy Now GET FREE SAMPLE
    C-reactive Protein Testing Market
    Buy Now GET FREE SAMPLE
    Blood Testing Market
    Buy Now GET FREE SAMPLE
    Protein Assays Market
    Buy Now GET FREE SAMPLE
    Infectious Disease Diagnostics Market
    Buy Now GET FREE SAMPLE
    Molecular Diagnostics Market
    Buy Now GET FREE SAMPLE
    Hematology Diagnostics Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Immunoprotein Diagnostic Testing Market

    Report ID: SQMIG35A2600

    $5,300
    BUY NOW